In the News

386 News Items found
MSK medical oncologist Luis Diaz, Jr.
In the Clinic
A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Mushrooms growing on a mossy log on the forest floor
Dr. Gary Deng of the Integrative Medicine Service helps separate the hype from the proven health benefits of mushroom supplements.
Jimmie Holland in early 1990s
In Memoriam
Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer. She also made huge strides in reducing the stigma surrounding the disease.
Male scientist wearing protective gear working with radiopharmaceutical materials.
Article
Thanks to pioneering work done at MSK, a powerful new form of radiation therapy is changing the treatment of advanced cancers.
Jedd Wolchok in his lab
In the Lab
During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.
(Left to right) Medical oncologist Mark Robson, gynecologist Noah Kauff, medical oncologist Zsofia Stadler, and Clinical Genetics Service Chief Kenneth Offit are applying genetic insights to improve the care of cancer patients.
At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.
Julia Glade Bender and her niece Emily
MSK doctors, such as Julia Glade Bender, are achieving better outcomes for patients by personalizing treatment on the basis of the biology of the cancer rather than the patient’s age.
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
In the Lab
Targeting this signal with drugs might be one way to stop cancers from spreading.
A micrograph image of breast cancer cells.
In the Lab
MSK investigators are studying how dormant cancer cells can become reactivated after remaining hidden in the body for years.